Achieve recently announced that the FDA accepted its cytisinicline New Drug Application for treatment of nicotine dependence for smoking cessation, with a PDUFA target action date of June 20, 2026.
The Cool Down on MSN
Alarming new study reveals overlooked side effect of vaping on young people: 'The evidence supports policy measures'
Some reviews in the analysis also noted a higher chance of young people who vape turning to marijuana, alcohol, and stimulant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback